Found 225 hits with Last Name = 'miller' and Initial = 'pb' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268371
(CHEMBL502247 | N-(2-((1S,2R,4R)-4-(isopropyl(methy...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C28H36F3N3O4S2/c1-18(2)34(3)22-8-13-25(20(15-22)17-40(37,38)24-11-9-23(39-4)10-12-24)33-26(35)16-32-27(36)19-6-5-7-21(14-19)28(29,30)31/h5-7,9-12,14,18,20,22,25H,8,13,15-17H2,1-4H3,(H,32,36)(H,33,35)/t20-,22+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxis |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268423
(CHEMBL497202 | N-(2-((1S,2R,4R)-4-(dimethylamino)-...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C |r| Show InChI InChI=1S/C26H32F3N3O4S2/c1-32(2)20-7-12-23(18(14-20)16-38(35,36)22-10-8-21(37-3)9-11-22)31-24(33)15-30-25(34)17-5-4-6-19(13-17)26(27,28)29/h4-6,8-11,13,18,20,23H,7,12,14-16H2,1-3H3,(H,30,34)(H,31,33)/t18-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced calcium flux by fluorescence-imaging plate reader assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315998
(CHEMBL1090893 | N-((S)-1-((1S,2R,4R)-4-(ethyl(isop...)Show SMILES CCN(C(C)C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cccc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C30H38F3N3O4S/c1-4-35(20(2)3)24-13-14-27(22(18-24)19-41(39,40)25-11-6-5-7-12-25)36-16-15-26(29(36)38)34-28(37)21-9-8-10-23(17-21)30(31,32)33/h5-12,17,20,22,24,26-27H,4,13-16,18-19H2,1-3H3,(H,34,37)/t22-,24+,26-,27-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268423
(CHEMBL497202 | N-(2-((1S,2R,4R)-4-(dimethylamino)-...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C |r| Show InChI InChI=1S/C26H32F3N3O4S2/c1-32(2)20-7-12-23(18(14-20)16-38(35,36)22-10-8-21(37-3)9-11-22)31-24(33)15-30-25(34)17-5-4-6-19(13-17)26(27,28)29/h4-6,8-11,13,18,20,23H,7,12,14-16H2,1-3H3,(H,30,34)(H,31,33)/t18-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.370 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315992
(CHEMBL1092678 | N-((S)-1-((1S,2R,4R)-4-(isopropyl(...)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccc(C)cc2)C1)N1CC[C@H](NC(=O)c2cccc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C30H38F3N3O4S/c1-19(2)35(4)24-10-13-27(22(17-24)18-41(39,40)25-11-8-20(3)9-12-25)36-15-14-26(29(36)38)34-28(37)21-6-5-7-23(16-21)30(31,32)33/h5-9,11-12,16,19,22,24,26-27H,10,13-15,17-18H2,1-4H3,(H,34,37)/t22-,24+,26-,27-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268371
(CHEMBL502247 | N-(2-((1S,2R,4R)-4-(isopropyl(methy...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C28H36F3N3O4S2/c1-18(2)34(3)22-8-13-25(20(15-22)17-40(37,38)24-11-9-23(39-4)10-12-24)33-26(35)16-32-27(36)19-6-5-7-21(14-19)28(29,30)31/h5-7,9-12,14,18,20,22,25H,8,13,15-17H2,1-4H3,(H,32,36)(H,33,35)/t20-,22+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced calcium flux by fluorescence-imaging plate reader assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315993
(CHEMBL1091605 | N-((S)-1-((1S,2R,4R)-4-(isopropyl(...)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cccc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C29H36F3N3O4S/c1-19(2)34(3)23-12-13-26(21(17-23)18-40(38,39)24-10-5-4-6-11-24)35-15-14-25(28(35)37)33-27(36)20-8-7-9-22(16-20)29(30,31)32/h4-11,16,19,21,23,25-26H,12-15,17-18H2,1-3H3,(H,33,36)/t21-,23+,25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis after 45 mins in presence of 0.1 M bovine serum albumin |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268424
(CHEMBL502793 | N-(2-((1S,2R,4R)-4-(diethylamino)-2...)Show SMILES CCN(CC)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(SC)cc2)C1 |r| Show InChI InChI=1S/C28H36F3N3O4S2/c1-4-34(5-2)22-9-14-25(20(16-22)18-40(37,38)24-12-10-23(39-3)11-13-24)33-26(35)17-32-27(36)19-7-6-8-21(15-19)28(29,30)31/h6-8,10-13,15,20,22,25H,4-5,9,14,16-18H2,1-3H3,(H,32,36)(H,33,35)/t20-,22+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced calcium flux by fluorescence-imaging plate reader assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315989
(3-fluoro-N-((S)-1-((1S,2R,4R)-4-(isopropyl(methyl)...)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cc(F)cc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C29H35F4N3O4S/c1-18(2)35(3)23-9-10-26(20(15-23)17-41(39,40)24-7-5-4-6-8-24)36-12-11-25(28(36)38)34-27(37)19-13-21(29(31,32)33)16-22(30)14-19/h4-8,13-14,16,18,20,23,25-26H,9-12,15,17H2,1-3H3,(H,34,37)/t20-,23+,25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315994
(CHEMBL1091604 | N-(2-((1S,2R,4R)-4-(isopropyl(meth...)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccccc2)C1 |r| Show InChI InChI=1S/C27H34F3N3O4S/c1-18(2)33(3)22-12-13-24(20(15-22)17-38(36,37)23-10-5-4-6-11-23)32-25(34)16-31-26(35)19-8-7-9-21(14-19)27(28,29)30/h4-11,14,18,20,22,24H,12-13,15-17H2,1-3H3,(H,31,35)(H,32,34)/t20-,22+,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391012
(CHEMBL2088212)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)Cc2nc3cccc(c3[nH]2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(Br)cc2)C1 |r| Show InChI InChI=1S/C27H32BrF3N4O3S/c1-16(2)35(3)19-9-12-22(17(13-19)15-39(37,38)20-10-7-18(28)8-11-20)33-25(36)14-24-32-23-6-4-5-21(26(23)34-24)27(29,30)31/h4-8,10-11,16-17,19,22H,9,12-15H2,1-3H3,(H,32,34)(H,33,36)/t17-,19+,22-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50233341
(2-(3-isopropylureido)-N-(2-((1S,2R)-2-(4-(methylth...)Show SMILES CSc1ccc(cc1)C(=O)N[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)NC(C)C)C(F)(F)F |r| Show InChI InChI=1S/C28H34F3N5O4S/c1-16(2)33-27(40)36-21-13-10-18(28(29,30)31)14-20(21)26(39)32-15-24(37)34-22-6-4-5-7-23(22)35-25(38)17-8-11-19(41-3)12-9-17/h8-14,16,22-23H,4-7,15H2,1-3H3,(H,32,39)(H,34,37)(H,35,38)(H2,33,36,40)/t22-,23+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxis |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315993
(CHEMBL1091605 | N-((S)-1-((1S,2R,4R)-4-(isopropyl(...)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cccc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C29H36F3N3O4S/c1-19(2)34(3)23-12-13-26(21(17-23)18-40(38,39)24-10-5-4-6-11-24)35-15-14-25(28(35)37)33-27(36)20-8-7-9-22(16-20)29(30,31)32/h4-11,16,19,21,23,25-26H,12-15,17-18H2,1-3H3,(H,33,36)/t21-,23+,25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268426
(2-amino-N-(2-((1S,2R,4R)-4-(isopropyl(methyl)amino...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1N)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C28H37F3N4O4S2/c1-17(2)35(3)20-6-12-25(18(13-20)16-41(38,39)22-9-7-21(40-4)8-10-22)34-26(36)15-33-27(37)23-14-19(28(29,30)31)5-11-24(23)32/h5,7-11,14,17-18,20,25H,6,12-13,15-16,32H2,1-4H3,(H,33,37)(H,34,36)/t18-,20+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxis |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391023
(CHEMBL2088388)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CCC(C1=O)c1nc2cccc(c2[nH]1)C(F)(F)F |r| Show InChI InChI=1S/C29H35F3N4O3S/c1-18(2)35(3)20-12-13-25(19(16-20)17-40(38,39)21-8-5-4-6-9-21)36-15-14-22(28(36)37)27-33-24-11-7-10-23(26(24)34-27)29(30,31)32/h4-11,18-20,22,25H,12-17H2,1-3H3,(H,33,34)/t19-,20+,22?,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315994
(CHEMBL1091604 | N-(2-((1S,2R,4R)-4-(isopropyl(meth...)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccccc2)C1 |r| Show InChI InChI=1S/C27H34F3N3O4S/c1-18(2)33(3)22-12-13-24(20(15-22)17-38(36,37)23-10-5-4-6-11-23)32-25(34)16-31-26(35)19-8-7-9-21(14-19)27(28,29)30/h4-11,14,18,20,22,24H,12-13,15-17H2,1-3H3,(H,31,35)(H,32,34)/t20-,22+,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis after 45 mins in presence of 0.1 M bovine serum albumin |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268371
(CHEMBL502247 | N-(2-((1S,2R,4R)-4-(isopropyl(methy...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C28H36F3N3O4S2/c1-18(2)34(3)22-8-13-25(20(15-22)17-40(37,38)24-11-9-23(39-4)10-12-24)33-26(35)16-32-27(36)19-6-5-7-21(14-19)28(29,30)31/h5-7,9-12,14,18,20,22,25H,8,13,15-17H2,1-4H3,(H,32,36)(H,33,35)/t20-,22+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268424
(CHEMBL502793 | N-(2-((1S,2R,4R)-4-(diethylamino)-2...)Show SMILES CCN(CC)[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(SC)cc2)C1 |r| Show InChI InChI=1S/C28H36F3N3O4S2/c1-4-34(5-2)22-9-14-25(20(16-22)18-40(37,38)24-12-10-23(39-3)11-13-24)33-26(35)17-32-27(36)19-7-6-8-21(15-19)28(29,30)31/h6-8,10-13,15,20,22,25H,4-5,9,14,16-18H2,1-3H3,(H,32,36)(H,33,35)/t20-,22+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268426
(2-amino-N-(2-((1S,2R,4R)-4-(isopropyl(methyl)amino...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1N)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C28H37F3N4O4S2/c1-17(2)35(3)20-6-12-25(18(13-20)16-41(38,39)22-9-7-21(40-4)8-10-22)34-26(36)15-33-27(37)23-14-19(28(29,30)31)5-11-24(23)32/h5,7-11,14,17-18,20,25H,6,12-13,15-16,32H2,1-4H3,(H,33,37)(H,34,36)/t18-,20+,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268368
(CHEMBL496630 | N-(2-((1S,2R,4R)-4-(methylamino)-2-...)Show SMILES CN[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(SC)cc2)C1 |r| Show InChI InChI=1S/C25H30F3N3O4S2/c1-29-19-6-11-22(17(13-19)15-37(34,35)21-9-7-20(36-2)8-10-21)31-23(32)14-30-24(33)16-4-3-5-18(12-16)25(26,27)28/h3-5,7-10,12,17,19,22,29H,6,11,13-15H2,1-2H3,(H,30,33)(H,31,32)/t17-,19+,22-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced calcium flux by fluorescence-imaging plate reader assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315998
(CHEMBL1090893 | N-((S)-1-((1S,2R,4R)-4-(ethyl(isop...)Show SMILES CCN(C(C)C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cccc(c2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C30H38F3N3O4S/c1-4-35(20(2)3)24-13-14-27(22(18-24)19-41(39,40)25-11-6-5-7-12-25)36-16-15-26(29(36)38)34-28(37)21-9-8-10-23(17-21)30(31,32)33/h5-12,17,20,22,24,26-27H,4,13-16,18-19H2,1-3H3,(H,34,37)/t22-,24+,26-,27-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis after 45 mins in presence of 0.5 M bovine serum albumin |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391024
(CHEMBL2088389)Show SMILES CCN(C(C)C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CCC(C1=O)c1nc2cccc(c2[nH]1)C(F)(F)F |r| Show InChI InChI=1S/C30H37F3N4O3S/c1-4-36(19(2)3)21-13-14-26(20(17-21)18-41(39,40)22-9-6-5-7-10-22)37-16-15-23(29(37)38)28-34-25-12-8-11-24(27(25)35-28)30(31,32)33/h5-12,19-21,23,26H,4,13-18H2,1-3H3,(H,34,35)/t20-,21+,23?,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391015
(CHEMBL2088380)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)Cc2nc3cccc(c3[nH]2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(cc2)C#N)C1 |r| Show InChI InChI=1S/C28H32F3N5O3S/c1-17(2)36(3)20-9-12-23(19(13-20)16-40(38,39)21-10-7-18(15-32)8-11-21)34-26(37)14-25-33-24-6-4-5-22(27(24)35-25)28(29,30)31/h4-8,10-11,17,19-20,23H,9,12-14,16H2,1-3H3,(H,33,35)(H,34,37)/t19-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255219
((+/-)-benzyl-3-(4-(methylthio)benzamido)-4-(2-(3-(...)Show SMILES CSc1ccc(cc1)C(=O)NC1CC(CCC1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)NC(=O)OCc1ccccc1 Show InChI InChI=1S/C32H33F3N4O5S/c1-45-25-13-10-21(11-14-25)30(42)39-27-17-24(37-31(43)44-19-20-6-3-2-4-7-20)12-15-26(27)38-28(40)18-36-29(41)22-8-5-9-23(16-22)32(33,34)35/h2-11,13-14,16,24,26-27H,12,15,17-19H2,1H3,(H,36,41)(H,37,43)(H,38,40)(H,39,42) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human monocytes assessed as inhibition of MCP1-induced calcium influx by FLIPR |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255171
((+/-)-2-amino-N-(2-(5-(isopropylamino)-2-(4-(methy...)Show SMILES CSc1ccc(cc1)C(=O)NC1CCC(CC1NC(=O)CNC(=O)c1cc(ccc1N)C(F)(F)F)NC(C)C Show InChI InChI=1S/C27H34F3N5O3S/c1-15(2)33-18-7-11-22(35-25(37)16-4-8-19(39-3)9-5-16)23(13-18)34-24(36)14-32-26(38)20-12-17(27(28,29)30)6-10-21(20)31/h4-6,8-10,12,15,18,22-23,33H,7,11,13-14,31H2,1-3H3,(H,32,38)(H,34,36)(H,35,37) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human monocytes assessed as inhibition of MCP1-induced calcium influx by FLIPR |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268422
(CHEMBL502516 | N-(2-((1S,2R,4R)-4-(isopropylamino)...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)NC(C)C |r| Show InChI InChI=1S/C27H34F3N3O4S2/c1-17(2)32-21-7-12-24(19(14-21)16-39(36,37)23-10-8-22(38-3)9-11-23)33-25(34)15-31-26(35)18-5-4-6-20(13-18)27(28,29)30/h4-6,8-11,13,17,19,21,24,32H,7,12,14-16H2,1-3H3,(H,31,35)(H,33,34)/t19-,21+,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.05 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381179
(CHEMBL2018388)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCC1)C(F)(F)F |r| Show InChI InChI=1S/C29H38F3N5O4/c1-4-6-25(38)24(16-33-15-20-8-7-18(2)13-19(20)3)35-26(39)17-34-27(40)22-14-21(29(30,31)32)9-10-23(22)36-28(41)37-11-5-12-37/h7-10,13-14,24-25,33,38H,4-6,11-12,15-17H2,1-3H3,(H,34,40)(H,35,39)(H,36,41)/t24-,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268374
(CHEMBL500175 | tert-butyl 2-(2-((1S,2R,4R)-4-(isop...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)OC(C)(C)C)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C33H45F3N4O6S2/c1-20(2)40(6)23-9-15-27(21(16-23)19-48(44,45)25-12-10-24(47-7)11-13-25)38-29(41)18-37-30(42)26-17-22(33(34,35)36)8-14-28(26)39-31(43)46-32(3,4)5/h8,10-14,17,20-21,23,27H,9,15-16,18-19H2,1-7H3,(H,37,42)(H,38,41)(H,39,43)/t21-,23+,27-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxis |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255738
((+/-)-N-(2-(4-(dimethylamino)-2-(4-(methylthio)ben...)Show SMILES CSc1ccc(CNC2CC(CCC2NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)N(C)C)cc1 Show InChI InChI=1S/C26H33F3N4O2S/c1-33(2)20-9-12-22(23(14-20)30-15-17-7-10-21(36-3)11-8-17)32-24(34)16-31-25(35)18-5-4-6-19(13-18)26(27,28)29/h4-8,10-11,13,20,22-23,30H,9,12,14-16H2,1-3H3,(H,31,35)(H,32,34) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMCs |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391013
(CHEMBL2088378)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)Cc2nc3cccc(c3[nH]2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(C)cc2)C1 |r| Show InChI InChI=1S/C28H35F3N4O3S/c1-17(2)35(4)20-10-13-23(19(14-20)16-39(37,38)21-11-8-18(3)9-12-21)33-26(36)15-25-32-24-7-5-6-22(27(24)34-25)28(29,30)31/h5-9,11-12,17,19-20,23H,10,13-16H2,1-4H3,(H,32,34)(H,33,36)/t19-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human monocytes by chemotaxis assay in presence of 0.5% bovine serum albumin |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255219
((+/-)-benzyl-3-(4-(methylthio)benzamido)-4-(2-(3-(...)Show SMILES CSc1ccc(cc1)C(=O)NC1CC(CCC1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)NC(=O)OCc1ccccc1 Show InChI InChI=1S/C32H33F3N4O5S/c1-45-25-13-10-21(11-14-25)30(42)39-27-17-24(37-31(43)44-19-20-6-3-2-4-7-20)12-15-26(27)38-28(40)18-36-29(41)22-8-5-9-23(16-22)32(33,34)35/h2-11,13-14,16,24,26-27H,12,15,17-19H2,1H3,(H,36,41)(H,37,43)(H,38,40)(H,39,42) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMCs |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381182
(CHEMBL2018391)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCNCC1)C(F)(F)F |r| Show InChI InChI=1S/C30H41F3N6O4/c1-4-5-26(40)25(17-35-16-21-7-6-19(2)14-20(21)3)37-27(41)18-36-28(42)23-15-22(30(31,32)33)8-9-24(23)38-29(43)39-12-10-34-11-13-39/h6-9,14-15,25-26,34-35,40H,4-5,10-13,16-18H2,1-3H3,(H,36,42)(H,37,41)(H,38,43)/t25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268423
(CHEMBL497202 | N-(2-((1S,2R,4R)-4-(dimethylamino)-...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)N(C)C |r| Show InChI InChI=1S/C26H32F3N3O4S2/c1-32(2)20-7-12-23(18(14-20)16-38(35,36)22-10-8-21(37-3)9-11-22)31-24(33)15-30-25(34)17-5-4-6-19(13-17)26(27,28)29/h4-6,8-11,13,18,20,23H,7,12,14-16H2,1-3H3,(H,30,34)(H,31,33)/t18-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as MCP1-induced chemotaxis |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268366
(CHEMBL450231 | N-(2-(2-((1S,2R)-2-((4-(methylthio)...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCOCC1)C(F)(F)F |r| Show InChI InChI=1S/C29H35F3N4O6S2/c1-43-21-7-9-22(10-8-21)44(40,41)18-19-4-2-3-5-24(19)34-26(37)17-33-27(38)23-16-20(29(30,31)32)6-11-25(23)35-28(39)36-12-14-42-15-13-36/h6-11,16,19,24H,2-5,12-15,17-18H2,1H3,(H,33,38)(H,34,37)(H,35,39)/t19-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391014
(CHEMBL2088379)Show SMILES CCc1ccc(cc1)S(=O)(=O)C[C@@H]1C[C@@H](CC[C@@H]1NC(=O)Cc1nc2cccc(c2[nH]1)C(F)(F)F)N(C)C(C)C |r| Show InChI InChI=1S/C29H37F3N4O3S/c1-5-19-9-12-22(13-10-19)40(38,39)17-20-15-21(36(4)18(2)3)11-14-24(20)34-27(37)16-26-33-25-8-6-7-23(28(25)35-26)29(30,31)32/h6-10,12-13,18,20-21,24H,5,11,14-17H2,1-4H3,(H,33,35)(H,34,37)/t20-,21+,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255221
((+/-)-N-(2-(2-((1H-indol-5-yl)methylamino)-4-(dime...)Show SMILES CN(C)C1CCC(NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)C(C1)NCc1ccc2[nH]ccc2c1 Show InChI InChI=1S/C27H32F3N5O2/c1-35(2)21-7-9-23(24(14-21)32-15-17-6-8-22-18(12-17)10-11-31-22)34-25(36)16-33-26(37)19-4-3-5-20(13-19)27(28,29)30/h3-6,8,10-13,21,23-24,31-32H,7,9,14-16H2,1-2H3,(H,33,37)(H,34,36) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMCs |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50391013
(CHEMBL2088378)Show SMILES CC(C)N(C)[C@@H]1CC[C@H](NC(=O)Cc2nc3cccc(c3[nH]2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(C)cc2)C1 |r| Show InChI InChI=1S/C28H35F3N4O3S/c1-17(2)35(4)20-10-13-23(19(14-20)16-39(37,38)21-11-8-18(3)9-12-21)33-26(36)15-25-32-24-7-5-6-22(27(24)34-25)28(29,30)31/h5-9,11-12,17,19-20,23H,10,13-16H2,1-4H3,(H,32,34)(H,33,36)/t19-,20+,23-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Binding affinity to CCR2 |
Bioorg Med Chem Lett 22: 6181-4 (2012)
Article DOI: 10.1016/j.bmcl.2012.08.002 BindingDB Entry DOI: 10.7270/Q2F47Q62 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381174
(CHEMBL2018380)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1N)C(F)(F)F |r| Show InChI InChI=1S/C25H33F3N4O3/c1-4-5-22(33)21(13-30-12-17-7-6-15(2)10-16(17)3)32-23(34)14-31-24(35)19-11-18(25(26,27)28)8-9-20(19)29/h6-11,21-22,30,33H,4-5,12-14,29H2,1-3H3,(H,31,35)(H,32,34)/t21-,22-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50315990
(CHEMBL1092748 | N-((S)-1-((1S,2R,4R)-4-(isopropyl(...)Show SMILES CC(C)N(C)[C@@H]1CC[C@@H]([C@H](CS(=O)(=O)c2ccccc2)C1)N1CC[C@H](NC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C30H35F6N3O4S/c1-18(2)38(3)23-9-10-26(20(15-23)17-44(42,43)24-7-5-4-6-8-24)39-12-11-25(28(39)41)37-27(40)19-13-21(29(31,32)33)16-22(14-19)30(34,35)36/h4-8,13-14,16,18,20,23,25-26H,9-12,15,17H2,1-3H3,(H,37,40)/t20-,23+,25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]-MCP1 from CCR2 in human THP1 cells after 30 mins |
Bioorg Med Chem Lett 20: 2425-30 (2010)
Article DOI: 10.1016/j.bmcl.2010.03.035 BindingDB Entry DOI: 10.7270/Q2ZK5GTM |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381177
(CHEMBL2018386)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)NCC)C(F)(F)F |r| Show InChI InChI=1S/C28H38F3N5O4/c1-5-7-24(37)23(15-32-14-19-9-8-17(3)12-18(19)4)35-25(38)16-34-26(39)21-13-20(28(29,30)31)10-11-22(21)36-27(40)33-6-2/h8-13,23-24,32,37H,5-7,14-16H2,1-4H3,(H,34,39)(H,35,38)(H2,33,36,40)/t23-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268368
(CHEMBL496630 | N-(2-((1S,2R,4R)-4-(methylamino)-2-...)Show SMILES CN[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cccc(c2)C(F)(F)F)[C@H](CS(=O)(=O)c2ccc(SC)cc2)C1 |r| Show InChI InChI=1S/C25H30F3N3O4S2/c1-29-19-6-11-22(17(13-19)15-37(34,35)21-9-7-20(36-2)8-10-21)31-23(32)14-30-24(33)16-4-3-5-18(12-16)25(26,27)28/h3-5,7-10,12,17,19,22,29H,6,11,13-15H2,1-2H3,(H,30,33)(H,31,32)/t17-,19+,22-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50268364
(CHEMBL447937 | N-(2-(2-((1S,2R)-2-((4-(methylthio)...)Show SMILES CSc1ccc(cc1)S(=O)(=O)C[C@@H]1CCCC[C@@H]1NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCCC1)C(F)(F)F |r| Show InChI InChI=1S/C29H35F3N4O5S2/c1-42-21-9-11-22(12-10-21)43(40,41)18-19-6-2-3-7-24(19)34-26(37)17-33-27(38)23-16-20(29(30,31)32)8-13-25(23)35-28(39)36-14-4-5-15-36/h8-13,16,19,24H,2-7,14-15,17-18H2,1H3,(H,33,38)(H,34,37)(H,35,39)/t19-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMC by millipore filter plate assay |
Bioorg Med Chem Lett 19: 3418-22 (2009)
Article DOI: 10.1016/j.bmcl.2009.05.041 BindingDB Entry DOI: 10.7270/Q27W6C3X |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50255171
((+/-)-2-amino-N-(2-(5-(isopropylamino)-2-(4-(methy...)Show SMILES CSc1ccc(cc1)C(=O)NC1CCC(CC1NC(=O)CNC(=O)c1cc(ccc1N)C(F)(F)F)NC(C)C Show InChI InChI=1S/C27H34F3N5O3S/c1-15(2)33-18-7-11-22(35-25(37)16-4-8-19(39-3)9-5-16)23(13-18)34-24(36)14-32-26(38)20-12-17(27(28,29)30)6-10-21(20)31/h4-6,8-10,12,15,18,22-23,33H,7,11,13-14,31H2,1-3H3,(H,32,38)(H,34,36)(H,35,37) | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125I]MCP1 from CCR2 in human PBMCs |
Bioorg Med Chem Lett 19: 597-601 (2009)
Article DOI: 10.1016/j.bmcl.2008.12.062 BindingDB Entry DOI: 10.7270/Q2QF8SR1 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381188
(CHEMBL2018400)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CC(=O)Nc1cc(N)cc(c1)C(F)(F)F |r| Show InChI InChI=1S/C25H33F3N4O3/c1-4-5-22(33)21(14-30-13-17-7-6-15(2)8-16(17)3)32-24(35)12-23(34)31-20-10-18(25(26,27)28)9-19(29)11-20/h6-11,21-22,30,33H,4-5,12-14,29H2,1-3H3,(H,31,34)(H,32,35)/t21-,22-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381181
(CHEMBL2018390)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCOCC1)C(F)(F)F |r| Show InChI InChI=1S/C30H40F3N5O5/c1-4-5-26(39)25(17-34-16-21-7-6-19(2)14-20(21)3)36-27(40)18-35-28(41)23-15-22(30(31,32)33)8-9-24(23)37-29(42)38-10-12-43-13-11-38/h6-9,14-15,25-26,34,39H,4-5,10-13,16-18H2,1-3H3,(H,35,41)(H,36,40)(H,37,42)/t25-,26-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381175
(CHEMBL2018384)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)OC(C)(C)C)C(F)(F)F |r| Show InChI InChI=1S/C30H41F3N4O5/c1-7-8-25(38)24(16-34-15-20-10-9-18(2)13-19(20)3)36-26(39)17-35-27(40)22-14-21(30(31,32)33)11-12-23(22)37-28(41)42-29(4,5)6/h9-14,24-25,34,38H,7-8,15-17H2,1-6H3,(H,35,40)(H,36,39)(H,37,41)/t24-,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Mus musculus) | BDBM50381177
(CHEMBL2018386)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)NCC)C(F)(F)F |r| Show InChI InChI=1S/C28H38F3N5O4/c1-5-7-24(37)23(15-32-14-19-9-8-17(3)12-18(19)4)35-25(38)16-34-26(39)21-13-20(28(29,30)31)10-11-22(21)36-27(40)33-6-2/h8-13,23-24,32,37H,5-7,14-16H2,1-4H3,(H,34,39)(H,35,38)(H2,33,36,40)/t23-,24-/m0/s1 | Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in mouse monocytes assessed as inhibition of MCP1-induced chemotaxis |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381179
(CHEMBL2018388)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)N1CCC1)C(F)(F)F |r| Show InChI InChI=1S/C29H38F3N5O4/c1-4-6-25(38)24(16-33-15-20-8-7-18(2)13-19(20)3)35-26(39)17-34-27(40)22-14-21(29(30,31)32)9-10-23(22)36-28(41)37-11-5-12-37/h7-10,13-14,24-25,33,38H,4-6,11-12,15-17H2,1-3H3,(H,34,40)(H,35,39)(H,36,41)/t24-,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Antagonist activity at CCR2 in human PBMC assessed as inhibition of MCP1-induced chemotaxis |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381190
(CHEMBL2018402)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CC(=O)Nc1cc(NCC)cc(c1)C(F)(F)F |r| Show InChI InChI=1S/C27H37F3N4O3/c1-5-7-24(35)23(16-31-15-19-9-8-17(3)10-18(19)4)34-26(37)14-25(36)33-22-12-20(27(28,29)30)11-21(13-22)32-6-2/h8-13,23-24,31-32,35H,5-7,14-16H2,1-4H3,(H,33,36)(H,34,37)/t23-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50381178
(CHEMBL2018387)Show SMILES CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(ccc1NC(=O)NC(C)C)C(F)(F)F |r| Show InChI InChI=1S/C29H40F3N5O4/c1-6-7-25(38)24(15-33-14-20-9-8-18(4)12-19(20)5)36-26(39)16-34-27(40)22-13-21(29(30,31)32)10-11-23(22)37-28(41)35-17(2)3/h8-13,17,24-25,33,38H,6-7,14-16H2,1-5H3,(H,34,40)(H,36,39)(H2,35,37,41)/t24-,25-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
Curated by ChEMBL
| Assay Description Displacement of [125-I]MCP1 from CCR2 on human PBMC |
Bioorg Med Chem Lett 22: 3311-6 (2012)
Article DOI: 10.1016/j.bmcl.2012.03.007 BindingDB Entry DOI: 10.7270/Q2PN96MB |
More data for this Ligand-Target Pair | |